Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Osivelotor

Generic Name: Osivelotor

Drug Type: Small Molecule

Chemical Formula: C_₂₀H_₂₂N_₂O_₆

CAS Number: 2417955-18-9

Unique Ingredient Identifier: UK749B4S16

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Study to Learn How Different Preparations of Osivelotor Taste and Enter the Blood With Food or Liquids or With an Antacid in Healthy Adults

Phase 1

Not yet recruiting

Posted: 2024/07/18

Sponsor:Pfizer

ID:NCT06507904

A Study to Learn How the Body Processes the Study Medicine Called Osivelotor (PF-07940367) in People With Loss of Liver Function

Phase 1

Completed

Posted: 2024/04/01

Sponsor:Pfizer

ID:NCT06340347

A Study to Learn How Different Products of the Study Medicine Called PF-07940367 Are Taken up Into the Blood in Healthy Adults

Phase 1

Completed

Posted: 2024/01/05

Sponsor:Pfizer

ID:NCT06190561

Study of GBT021601 in Participants With Renal Impairment

Phase 1

Terminated

Posted: 2023/05/26

Sponsor:Pfizer

ID:NCT05878704

A GBT021601 ADME Microtracer Study in Healthy Volunteers

Phase 1

Completed

Posted: 2023/02/08

Sponsor:Pfizer

ID:NCT05718687

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy

Drug Development Updates

Osivelotor

Overview

Background

Indication

Associated Conditions

Clinical Trials

FDA Approved Products

Singapore Approved Products

Related News

Pfizer Withdraws Sickle Cell Disease Drug Oxbryta Globally Due to Safety Concerns

Drug Development Updates